Literature DB >> 184826

Activity of cholinephosphotransferase, lysolecithin: lysolecithin acyltransferase and lysolecithin acyltransferase in the developing mouse lung.

V Oldenborg, L M van Golde.   

Abstract

1. The present study presents the activity profiles of cholinephosphotransferase, lysolecithin:lysolecithin acyltransferase and lysolecithin acyltransferase at different stages of development of the mouse lung. 2. The specific activity of cholinephosphotransferase, a key enzyme in the de novo synthesis of phosphatidylcholine, increases during the later stages of fetal development until it reaches a maximal value at a gestational age of 17 days, i.e. 2 days before term. Thereafter, the activity of the enzyme declines again until around term. 2. The specific activity of lysolecithin:lysolecithin acyltransferase which catalyzes the transesterification between two molecules of 1-acyl-sn-glycero-3-phosphocholine, appears to be much lower than that of cholinephosphotransferase at gestational ages below 18 days. However, around day 18, the specific activity of lysolecithin:lysolecithin acyltransferase increases dramatically until it almost equals the maximal activity of cholinephosphotransferase measured on day 17. 4. The specific activity of lysolecithin acyltransferase, which catalyzes the direct acylation of 1-acyl-sn-glycero-3-phosphocholine, does not change significantly during the prenatal development and is lower than that of either lysolecithin:lysolecithin acyltransferase or cholinephosphotransferase at all stages of development. 5. These results are discussed in view of the possible role of these enzymes in the biosynthesis of pulmonary 1,2-dipalmitoyl-sn-glycero-3-phosphocholine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184826     DOI: 10.1016/0005-2760(76)90240-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Cholinephosphotransferase from rabbit lung microsomes. An improved assay and specificity towards exogenous diacylglycerols.

Authors:  S A Rooney; T S Wai-Lee
Journal:  Lung       Date:  1977       Impact factor: 2.584

2.  Theoretical approach to the steady-state kinetics of a bi-substrate acyl-transfer enzyme reaction that follows a hydrolysable-acyl-enzyme-based mechanism. Application to the study of lysophosphatidylcholine:lysophosphatidylcholine acyltransferase from rabbit lung.

Authors:  J Martín; J Pérez-Gil; C Acebal; R Arche
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

3.  Variations in the molecular species of lung phosphatidylglycerol.

Authors:  G Okano; T Akino
Journal:  Lipids       Date:  1979-06       Impact factor: 1.880

4.  Acyl CoA synthetase from rat lung: purification and properties.

Authors:  D K Das
Journal:  Lung       Date:  1982       Impact factor: 2.584

Review 5.  Isolated type II cells from fetal lung as model in studies on the synthesis and secretion of pulmonary surfactant.

Authors:  J J Batenburg
Journal:  Lung       Date:  1980       Impact factor: 2.584

6.  Substrate selectivity of acyl-CoA:lysolecithin acyltransferase from rabbit lung.

Authors:  P Estrada; C Acebal; R Arche
Journal:  Mol Cell Biochem       Date:  1985-11       Impact factor: 3.396

7.  Analysis of subcellular phosphatidyl choline in developing rabbit lung.

Authors:  G R Gutcher; R D Zachman; F H Tsao
Journal:  Lipids       Date:  1979-01       Impact factor: 1.880

8.  Enzymes of phospholipid metabolism in airway secretions of patients with asthma, cystic fibrosis, and alveolar proteinosis.

Authors:  S Sahu; W S Lynn
Journal:  Inflammation       Date:  1977-06       Impact factor: 4.092

9.  Study of properties of cholinephosphotransferase from fetal guinea pig lung mitochondria and microsomes.

Authors:  S Ghosh; P W Oten; S Mukherjee; S K Das
Journal:  Mol Cell Biochem       Date:  1991-03-13       Impact factor: 3.396

10.  Lipogenesis in liver, lung and adipose tissue of rats fed with oleoylanilide.

Authors:  C Casals; P Garcia-Barreno; A M Municio
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.